PR Newswire - Integrated cancer biotech Infinitopes secures £12....
Funding also supports the start of phase I/IIa study for lead vaccine, ITOP1 OXFORD, England, May 1, 2024 /PRNewswire/ -- Infinitopes Precision Immunomics, an integrated cancer biotech combining world...
Read More